According to Union Ministry of Health, India records 2,876 new coronavirus infections making the total tally of COVID-19 cases in the country to 4,29,98,938. While the active cases have reportedly dipped to 32,811, the total death count has climbed to 5,16,072 with 98 fresh fatalities as per 8 AM on March 16, 2022.
The active cases of COVID-19 in India comprise 0.08 per cent of the total infections, whereas the national COVID-19 recovery rate has seen an improvement peaking at 98.72 per cent. Here is the 2022 update for vaccines you should know about:
Which COVID-19 vaccines are licensed in India
Currently, India has a total of five licensed vaccines:
- Covishield (AstraZeneca’s vaccine manufactured by Serum Institute of India)
- Covaxin (manufactured by Bharat Biotech Limited)
- Sputnik – V
- Corbevax (India’s first homegrown “RBD protein sub-unit vaccine”)
- Covovax (manufactured by the Pune-based Serum Institute of India)
While Covishield, Covaxin and Sputnik – V can be administered as per their choice and availability to adults above 18 years of age, Covovax has been reserved only for emergency purposes strictly advised not to be taken without prescription from medics.
Which vaccine is for 12-14 years age groups?
As per Union Health Minister Mansukh Mandaviya, registration for the coronavirus vaccination for children in the age group of 12-14 years begins from Wednesday, March 16, 2022.
Those between 12-14 years of age are instructed to be administered the Corbevax manufactured by the Hyderabad-based pharma company Biological E Limited.Corbevax. This is a two-dose vaccine administered in an interval of 28 days.
Which vaccine is for age 15-18 years in India?
Vaccination for those between 15 to 18 age groups in India had begun on January 3, 2022. The Union Health Ministry has mandated that only Covaxin will be administered to teens and additional doses of the vaccine.
Follow https://www.nusify.co/ for latest updates on Science, Tech, Sports, Entertainment, Culture & all that matters to you.